Home
Storia in 1 fonti
How Timely, Precise Lab Data Drive Decisions from Discovery to Post-Marketing Surveillance
How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how de-identified laboratory data supports clinical development, commercial strategy, patient insights, and post-market evaluation. | How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how de-identified laboratory data supports clinical development, commercial strategy, patient insights, and post-market evaluation.
Raccontata da
fiercepharma.com
Timeline cronologica
- ·
BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
- ·
Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
Healthcare agencies remain at the forefront of pharmaceutical marketing, but new technologies and shifting political dynamics are putting more pressure on the industry. |…
- ·
Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
Merck & Co. and Kelun-Biotech's sac-TMT is on fire this week with details or first reports of three positive phase 3 trials. | Merck & Co. and Kelun-Biotech's sac-TMT is on fire…
- ·
How Timely, Precise Lab Data Drive Decisions from Discovery to Post-Marketing Surveillance
How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how de-identified laboratory data supports clinical…
- ·
Real-World Evidence in the AI Era: What You Can Unlock Depends on What You Build On
Written by Guy Amster, Senior Principal Machine Learning Engineer, Flatiron Health | The differentiator isn't algorithms; it's data quality. Discover the two critical bottlenecks…